Fast-acting cholera vaccine could curb outbreaks
15 June 2018 | By European Pharmaceutical Review
A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest.
List view / Grid view
Genomics
Genome sequencing of first 50,000 UK Biobank participants
6 April 2018 | By European Pharmaceutical Review
UK Biobank has announced a major initiative to sequence the full genomes of 50,000 UK Biobank volunteer participants...
Larotrectinib shows promise in paediatric patients with TRK gene mutations
5 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A new cancer drug has proven safe and effective for paediatric patients with a rare tumour gene mutation...
Does genome sequencing increase downstream costs?
26 March 2018 | By European Pharmaceutical Review
A pilot study has found that whole genome sequencing of healthy individuals and cardiology patients did not increase health care spending outside of the sequencing costs.
Blood and urine tests developed to indicate autism in children
20 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
International researchers believe that their new blood and urine tests which search for damage to proteins are the first of their kind to detect early autism spectrum disorders...
Blood-based epigenetic may hold clues to autism
24 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Epigenetic data reveals immune-response pathways that may prove critical to understanding autism...
PI3K inhibitors show hope for rare bone cancers
12 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
Neratinib defeats the Ras genes notorious for causing cancer
11 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
Microcapsules to enhance the efficiency of genome-editing
6 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
Bluebird bio joins the ABPI as a full member
14 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
The Association of the British Pharmaceutical Industry (ABPI) has admitted the American biotech bluebird bio, Inc. as a full member...
BC Platforms launches global genomics and clinical data analytics resource
13 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A world leader in genomic data has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data...
UK Biobank releases genetic data on 0.5m people
28 July 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Genetic data on half a million people was made available for research last week by the UK Biobank study. Information about participants’ health and well-being, key body measurements, their diet, occupational history, mental health and activity levels are also included...
83% of life science leaders believe blockchain will be adopted within 5 years
27 June 2017 | By The Pistoia Alliance
Just under a quarter (22%) of life science companies already using or experimenting with blockchain, but industry collaboration over security and storage standards is needed…
Collaboration is ‘game changer’ in delivering cell and gene therapies
19 June 2017 | By Niamh Marriott (European Pharmaceutical Review)
Collaboration between the pharmaceutical industry, patients and health regulators will be a ‘game changer’ in delivering exciting new cell and gene therapies to treat conditions like cancer and vision loss.
Follow: